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In eukaryotic cells, there is evidence for functional
coupling between transcription and processing of
pre-mRNAs. To better understand this coupling, we
performed a high-resolution kinetic analysis of tran-
scription and splicing in budding yeast. This revealed
that shortly after induction of transcription, RNA poly-
merase accumulates transiently around the 30 end of
the intron on two reporter genes. This apparent tran-
scriptional pause coincides with splicing factor
recruitment and with the first detection of spliced
mRNAand is repeatedperiodically thereafter.Pausing
requiresproductivesplicing, as it is lostuponmutation
of the intron and restored by suppressing the splicing
defect. The carboxy-terminal domain of the paused
polymerase large subunit is hyperphosphorylated on
serine 5, and phosphorylation of serine 2 is first de-
tected here. Phosphorylated polymerase also accu-
mulates around the 30 splice sites of constitutively ex-
pressed, endogenous yeast genes. We propose that
transcriptional pausing is imposed by a checkpoint
associated with cotranscriptional splicing.
INTRODUCTION
Most transcripts produced by eukaryotic RNA polymerase II
(RNAPII) undergo processing at their 50 ends (capping), 30 ends
(cleavage and polyadenylation), and internally (splicing to
remove introns). It is now widely accepted that many of these
modifications, especially capping and 30 end formation, occur
cotranscriptionally, that is, before transcription is completed
and the RNA is released from the site of transcription (Pandit
et al., 2008; Perales and Bentley 2009). Splicing can occur co-
or posttranscriptionally. For example, early electron micro-
graphs of Drosophila cells showed that many but not all introns
are removed cotranscriptionally (Beyer and Osheim, 1988). The
chromatin immunoprecipitation (ChIP) method has been used
to demonstrate the sequential recruitment of spliceosomal small
nuclear ribonucleoprotein particles (snRNPs) to the site of
transcription, indicating spliceosome assembly on nascent tran-
scripts in both yeast and mammalian cells (Go¨rnemann et al.,
2005; Lacadie and Rosbash, 2005; Listerman et al., 2006; Tardiff
et al., 2006; Moore et al., 2006). The carboxy-terminal domain582 Molecular Cell 40, 582–593, November 24, 2010 ª2010 Elsevier(CTD) of RNAPII large subunit binds a number of RNA processing
factors, including capping enzymes, certain splicing factors, and
30 end processing factors (Buratowski, 2009). Thus, one expla-
nation for the occurrence of cotranscriptional RNA processing
could be that it is simply a consequence of the cotranscriptional
recruitment of the factors involved. However, there is evidence,
at least in mammalian systems, that coupling between the
different processes is functionally important (Kornblihtt et al.,
2004; Neugebauer, 2006; Pandit et al., 2008; Perales and Bent-
ley, 2009).
The CTD consists of multiple repeats (52 inmammals and 26 in
budding yeast) of the heptapeptide sequence YSPTSPS that is
dynamically phosphorylated during cycles of transcription
(Buratowski, 2009). Typically, the CTD is in a hypophosphory-
lated form at the promoter. At initiation of transcription, the serine
at position 5 (Ser5) becomes phosphorylated to permit promoter
clearance. This also promotes recruitment of the capping
enzymes. As RNAPII elongates toward the 30 end of the gene,
Ser5 phosphorylation declines and there is increased phosphor-
ylation of Ser2, which promotes recruitment of the 30 end
processing factors (Licatalosi et al., 2002). Recently, Ser7 in
theCTDwas found to be phosphorylated in amanner resembling
that of Ser5 (Egloff et al., 2007; Kim et al., 2009), in addition to
which, promoter-distal phosphorylated Ser7 (pSer7) was found
on genes transcribed by RNAPII (Tietjen et al., 2010). Currently,
the only characterized function for pSer7 is related to 30 end
processing of small nuclear RNAs (snRNAs) (Egloff et al.,
2007). Therefore, the CTD was proposed to function as
a ‘‘landing pad’’ for the recruitment of RNA processing factors,
with the specificity being determined by a ‘‘CTD code’’ of post-
translational modifications (Egloff and Murphy, 2008). Further-
more, the dynamic phosphorylation state of RNAPII is thought
to play an important role in the regulation of splicing (Batsche´
et al., 2006; Kornblihtt, 2006; Pandit et al., 2008).
Changing the dynamics of transcript elongation can also influ-
ence downstream processing events and can affect constitutive
or alternative splicing (Kadener et al., 2001; Nogues et al., 2002;
de la Mata et al., 2003; Howe et al., 2003). It was proposed that
the rate of transcriptional elongation can affect inclusion or skip-
ping of an alternative exon by controlling the duration of
a ‘‘window of opportunity’’ during which the splicing machinery
can recognize an upstream splice site and assemble a spliceo-
some before the appearance of a competing downstream splice
site (Kornblihtt et al., 2004; Perales and Bentley, 2009).
Conversely, splicing signals and splicing factors can enhance
transcriptional activity (Furger et al., 2002; Damgaard et al.,
2008; Lin et al., 2008), suggesting reciprocal interactions.Inc.
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tion and splicing, using a series of reporter genes in budding
yeast. We demonstrate repeated splicing-dependent transcrip-
tional pausing at the 30 end of the introns in two different reporter
genes. The CTD of the paused polymerase is hyperphosphory-
lated on Ser5 compared to its status at the promoter, and it
becomes phosphorylated on Ser2 at this point. We also demon-
strate elevated levels of phosphorylated RNAPII over the 30
splice sites of several endogenous yeast genes, suggesting
that this is a general phenomenon. We propose that transcrip-
tional pausing is imposed by a checkpoint that is associated
with cotranscriptional splicing. We discuss candidate proteins
that might function as checkpoint factors and speculate that
multiple checkpoints may exist that correspond to surveillance
mechanisms operating at different stages of the splicing
process.
RESULTS
To follow the in vivo kinetics of pre-mRNA splicing in Saccharo-
myces cerevisiae, we integrated reporters based on hybrid
ACT1-PGK1 sequences (Hilleren and Parker 2003; Alexander
et al., 2010) into the genome at the HIS3 locus under either tetra-
cycline-inducible (tetON) or tetracycline-repressible (tetOFF)
control (Bellı´ et al., 1998). Both the tetON and tetOFF strains
express tetracycline-responsive repressor and tetracycline-
responsive transactivator proteins, which provides a good
dynamic range of gene expression (Bellı´ et al. [1998]; in this
work, the tetracycline analog doxycyclin was used). The 1.3 kb
Ribo1 gene (Figure 1A; see the Supplemental Experimental
Procedures available online for full details) contains the budding
yeastACT1 intron with a short insertion to allow the transcripts to
be distinguished from endogenous ACT1 transcripts in reverse
transcriptase quantitative real-time PCR (RT-qPCR) assays.
Variants of this reporter contain a point mutation at the 50 splice
site (50SSRibo1), 30 splice site (30SSRibo1), or branch site
(BSRibo1) or lack an intron (ILRibo1) (Hilleren and Parker 2003;
Alexander et al., 2010). Addition of doxycyclin to the growth
medium of a tetON Ribo1 strain resulted in the transient low level
accumulation of Ribo1 pre-mRNA at about 3 min, followed by
spliced Ribo1 mRNA from 4 min, indicating splicing activity
(Figure 1B, Ribo1). Similarly, ILRibo1 mRNA was detectable
from 3 min (Figure 1B, ILRibo1).
ChIP assays, using antibodies against the Rpb3p subunit of
RNAPII, detected RNAPII recruitment to the promoter region
of the Ribo1 and ILRibo1 genes by 3 min after doxycyclin addi-
tion, and the level of RNAPII at the promoter then remained
above the uninduced level (Figure 1C; qPCR amplicon 1, indi-
cated in Figure 1A). At 4 min (when spliced mRNA was first
detectable), a strong, transient accumulation of RNAPII was
observed around the 30SS and just downstream at the 50 end
of exon 2 of Ribo1 (amplicons 3 and 4; Figures 1D and 1E; see
Figure S1 for the full dataset) but not in the corresponding region
of ILRibo1 (amplicon 4; Figures 1D and 1E). Note that the Rpb3p
ChIP signal is low over the exon1/50SS region (amplicon 2),
showing that RNAPII levels on either side, at the promoter and
30SS, can be distinguished in this assay (Ribo1 in Figure 1E
and Figures S1A–S1C). From 5.5min, there was also a persistentMolecRNAPII signal toward the 30 end of Ribo1 that was consistently
higher than the signal at the 30 end of ILRibo1, although the latter
appeared earlier, from 3 min (amplicon 5; Figure 1E). These
results were highly reproducible and were similar upon dere-
pression of tetOFF strains (data not shown). Although the timing
of the first detection of transcripts varied slightly between
different cultures, the transient accumulation of RNAPII in the
30SS region always coincided with the appearance of spliced
Ribo1 mRNA. In several experiments, two peaks of RNAPII
were detected at or near the 30 splice site, a few minutes apart
(e.g., Figure S1C).
We next tested the effect of point mutations at the 50SS or 30SS
(Figure 1A), which abolish the first or second step of splicing,
respectively. Unspliced 50SSRibo1 transcripts accumulated
from about 3 min and, as expected, no spliced mRNA was
detectable (Figure 1B, 50SSRibo1). 30SSRibo1RNA is a substrate
for the first but not the second step of splicing, and the lariat
intron-exon 2 product of the first step accumulated with a delay
of about 30 s after the appearance of pre-mRNA (Figure 1B,
30SSRibo1). ChIP assays showed RNAPII accumulation at the
promoter of eachmutant reporter gene (Figure 1C), but to a lower
level than with the Ribo1 gene, suggesting reduced transcrip-
tional activity, and there was no accumulation of RNAPII around
the 30SS (Figures 1D and 1E; amplicons 3 and 4). Thus, the tran-
sient RNAPII accumulation around the 30SS region of the Ribo1
gene depends on the presence of a fully functional intron and/
or completion of the splicing reaction, and neither spliceosome
assembly nor the first step of splicing is sufficient to cause
this. However, with the 30SSRibo1 reporter, we observed
a persistent accumulation of RNAPII over the exon1/50SS (ampli-
con 2), suggesting that in the absence of a functional 30SS, there
is a change in the dynamics of transcript elongation, with RNAPII
slowing its elongation rate or pausing over exon1/50SS.
The phosphorylation status of the CTD was also monitored by
ChIP, using antibodies specific for phosphorylated serine 5
(pSer5) or phosphorylated serine 2 (pSer2) (Kim et al., 2009).
This showed that, as expected, RNAPII at the promoter of
Ribo1 had mainly pSer5 (Figure 2A). The RNAPII that accumu-
lated transiently around the 30SS at 4 min was also highly phos-
phorylated on Ser5, and pSer5 RNAPII accumulated transiently
at the 30SS again a fewminutes later (Figure S2C). Notably, there
was little or no pSer5 detected between the promoter and the
30SS (amplicon 2 in Figure 2A, left panel). The paused RNAPII
was also phosphorylated on Ser2 (Figure 2A, right panel; Fig-
ure S2C), with the 30SS being the most 50 position on the gene
at which pSer2 was detected. This suggests that phosphoryla-
tion of Ser2 occurred on the paused RNAPII; however, the
pSer2 accumulation may not display exactly the same timing
as the pSer5 data. Toward the 30 end of the gene, pSer5
declined, whereas pSer2 increased at later time points. Present-
ing the RNAPII phosphorylation signal as a proportion of the total
RNAPII signal shows that RNAPII at the 30SS was hyperphos-
phorylated compared to RNAPII at the promoter (Figure S2,
pSer5/RNAPII, compare A and C). This suggests new phosphor-
ylation of Ser5 and Ser2 at the 30SS.
With the intronless ILRibo1 reporter, the pSer5 signal simply
decreased from the promoter toward the 30 end of the gene, as
the pSer2 signal gradually increased (Figure 2B). Withular Cell 40, 582–593, November 24, 2010 ª2010 Elsevier Inc. 583
Figure 1. Analysis of Ribo Reporter Induction
(A) Diagram of Ribo1, ILRibo1, 50SSRibo1, and 30SSRibo1 genes. Exons are represented by rectangles, and the intron by a line with sequences at the ends. The
reporter genes are based on previously described ACT1-PGK1 constructs (Hilleren and Parker, 2003; Alexander et al., 2010) expressed under control of a tetO7-
CYC1-UAS promoter (Bellı´ et al., 1998). The lines above indicate amplicons analyzed in RT-qPCR or ChIP analyses: 1, 2, 3, 4, and 5 correspond to the promoter,
exon 1/50SS, 30SS, 50 end of exon 2 and 30 end of exon 2, respectively. Amplicon 20 corresponds to spliced Ribo1 mRNA or the 50 end of the intronless ILRibo1.
Lariat introns (6) were assayed with an oligo that hybridizes across the 20-50phosphodiester bond at the branch site (Vogel et al., 1997). See the Supplemental
Information for full details of strains, reporter genes, and primer sequences.
(B) RT-qPCR analysis of accumulation of pre-mRNA, mRNA, or lariat RNA species (amplicon indicated in parentheses) showing the increase compared to time of
doxycyclin addition (T0). Error bars indicate standard error for RT performed in triplicate and qPCR also performed in triplicate.
(C) ChIP analysis (presented as percentage of input relative to uninduced level at T0) to detect RNAPII at the promoter (amplicon 1) using anti-Rpb3 antibodies
(Neoclone) with the same cultures as above.
(D) ChIP analysis to detect RNAPII at the 50 end of exon 2 (amplicon 4), otherwise as above.
(E) 3D representation of the RNAPII ChIP data, showing RNAPII occupancy at all positions tested (x axis) at times indicated on the z axis. In ChIP assays, error bars
indicate standard error for qPCR performed in triplicate. The kinetic resolution of the ChIP assay was tested by RT-qPCR measurement of Ribo1 transcription
during the formaldehyde treatment, showing that transcript accumulation ceases immediately, and indicating that RNAPII activity is halted very rapidly (data not
shown).
See also Figure S1.
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Figure 2. Phosphorylation Status of RNAPII
CTD during Induction
Top: Diagrams showing RNAPII CTD heptad
repeat with antibodies to detect pSer5 (4H8; Milli-
pore) or pSer2 (H5; Covance).
(A–D) ChIP analysis to detect RNAPII with pSer5
(left) or pSer2 (right) at different times after dox
addition (z axis), at all positions tested (x axis) for
Ribo1, ILRibo1, 50SSRibo1, and 30SSRibo1 as
indicated. Data are plotted in 3D and presented
as percentage input relative to T0. Other details
are as in Figure 1.
See also Figure S2.
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Splicing-Dependent RNA Polymerase Pausing in Yeast50SSRibo1, RNAPII with pSer5 accumulated strongly at the
promoter, despite the lower level of total RNAPII signal, and
there was only a low level of pSer2 across the body of the
gene, more like ILRibo1 than Ribo1 (Figure 2). With 30SSRibo1
(Figure 2D), there was an accumulation of pSer5 at the promoter
and also over the exon1/50SS (amplicon 2), compatible with
a slowing or pausing of RNAPII in this region. The level ofMolecular Cell 40, 582–593, NpSer2 increased toward the 30 end of
the 30SSRibo1 gene. Thus, the dynamics
of RNAPII phosphorylation differ signifi-
cantly with the splicing status of the gene.
If the RNAPII pause in the region of the
30SS is determined by splicing, two
predictions can be made: (1) splicing of
Ribo1 transcripts should be cotranscrip-
tional at this time and (2) suppression of
the splicing defect of a mutant intron will
lead to RNAPII pausing on the mutant
gene.
To address the first point, we analyzed
the cotranscriptional recruitment of U2
and U5 snRNPs by performing ChIP
with antibodies to the snRNP compo-
nents Prp11p and Prp8p, respectively.
U2 snRNP was detectable at 3.5 min
after doxycyclin addition, and the U5
snRNP was first detected at 4 min (Fig-
ure 3), consistent with cotranscriptional
spliceosome assembly at the time of the
RNAPII pause (Go¨rnemann et al., 2005)
and continuing thereafter. Furthermore,
we have recently shown in a kinetic anal-
ysis of splicing and 30 end formation that
a significant amount of splicing of Ribo1
transcripts occurs prior to 30 end
cleavage and polyadenylation, indicating
cotranscriptional splicing (Alexander
et al., 2010). It is therefore conceivable
that cotranscriptionally recruited splicing
factors might affect RNAPII and/or chro-
matin factors that are in close proximity.
To test the second prediction, we used
the BSRibo1 reporter that has a pointmutation at the branch site, which causes a first step splicing
defect. This splicing defect can be largely suppressed by
a mutant U2 snRNA that restores base pairing with the mutant
branch site sequence (Parker et al., 1987) (Figure 4A). Plasmids
encoding the wild-type or mutant U2 snRNA were introduced
into a tetOFF BSRibo1 strain. After derepression in the wild-
type U2 control strain, unspliced transcripts accumulated withovember 24, 2010 ª2010 Elsevier Inc. 585
Figure 3. Cotranscriptional Recruitment of Splicing Factors
(A and B) The positions on Ribo1 (A) at which recruitment of Prp11p (U2
snRNP; black) or Prp8p (U5 snRNP; gray) was detected by ChIP as shown
in (B), using the same culture as in Figure 1B. Error bars indicate standard error
for qPCR performed in triplicate. Arrows below indicate the times at which pre-
mRNA and spliced mRNA were first detected.
(C and D) 3D representations of the ChIP data for Prp11p and Prp8p respec-
tively at different positions on the Ribo1 gene (x axis) and at different times
after dox addition (z axis).
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RNAPII accumulation around the 30SS (Figures 4D and 4E; am-
plicons 3 and 4). This resembles the ILRibo1 and 50SSRibo1
result (Figure 1D). In a strain producing mutant U2 snRNA that
complements the BSRibo1 mutation, splicing was substantially
restored (Figure 4B, right panel). Importantly, RNAPII accumu-586 Molecular Cell 40, 582–593, November 24, 2010 ª2010 Elsevierlated transiently at the 30SS at 6.5 min, the time when spliced
mRNA was first detected, and a second peak of RNAPII ap-
peared at the 30SSat 8.5min (Figure 4D right panel; see Figure S3
for more detail and ChIP data for pSer5 and pSer2). Thus, it is
clearly the actual process of splicing, rather than the intron
sequence, that causes transient RNAPII pausing. Additionally,
it may be significant that suppression of the BS splicing defect
also resulted in higher levels of pSer2 RNAPII toward the 30
end of exon 2 (amplicon 5; Figure 4E and Figure S3E) as was
noted earlier for Ribo1, suggesting that this too may be splicing
dependent.
The observation of a second RNAPII pause in several experi-
ments raised the possibility that pausing may be a recurring
event. To test this, we performed a longer time course of
Ribo1 induction, and, indeed, RNAPII was observed to accumu-
late strongly near the 30SS three times, at approximately 3 min
intervals (Figure 5 and Figure S4). Intriguingly, each RNAPII
pause seems to occur at or shortly after a peak in pre-mRNA
accumulation and increased mRNA production, suggesting
bursts of splicing at these times.
The majority of intron-containing genes are constitutively ex-
pressed during normal growth in budding yeast. Therefore, in
order to examine another intron-containing gene under similar
induction conditions, the nonessential APE2 gene was deleted
from its genomic locus in the tetON yeast strain, and the APE2
sequence, was integrated downstream of the doxycyclin-induc-
ible promoter at the HIS3 locus (like Ribo1). An advantage of
APE2 for this analysis is that both of its exons are longer than
for Ribo1, allowing qPCR analysis of more, nonoverlapping,
regions of the APE2 gene. After the addition of doxycyclin,
RNAPII occupancy on the gene was monitored as for Ribo1.
As shown in Figure 6C, oscillations of RNAPII accumulation
were observed in the region of the 30SS, with a periodicity of
2.5 to 3 min. There was also increased RNAPII accumulation
toward the 30 end of the gene (Figure 6C, and more detail in Fig-
ure S5). Analysis of the phosphorylation status showed RNAPII
with pSer5 in the promoter region and in the transient peaks
over the 30SS (Figure 6 and Figure S5). The pSer2 signal also
increased from this point toward the 30 end of the gene. There-
fore, the APE2 and Ribo1 genes show similar patterns of
RNAPII accumulation after induction.
Although RNAPII pauses only very briefly at the end of the
Ribo1 and APE2 introns, the observation that pausing occurs
repeatedly suggested that it may be possible to detect an
elevated level of RNAPII over 30 splice sites of constitutively
expressed endogenous genes, without inducing synchronous
transcription in the population of cells. However, with an asyn-
chronous population of cells, the length, amplitude, and
frequency of the pause or oscillation will determine how readily
an elevated level of RNAPII will be detectable above background
in the snapshot in time that is captured by the ChIP assay.
Clearly, this may vary between genes. ChIP of RNAPII performed
on four endogenous intron-containing genes, including APE2,
shows that the level of RNAPII is slightly elevated over the
30SS of all four genes, although the resolution is poor (Figure S6).
As it had been shown that the level of phosphorylation of RNAPII
is significantly elevated around the 30SS of Ribo1 (Figure 2) and
APE2 (Figure 6), the amount of phosphorylated RNAPII wasInc.
Figure 4. It Is the Splicing Event Rather than the Intron Sequence that Causes RNAPII to Pause at the 30SS
(A) Diagram showing BSRibo1 mutant branchsite sequence base paired to WT U2 snRNA (left) and to mutant U2 snRNA (right).
(B) RT-qPCR analysis of BSRibo1 pre-mRNA and spliced mRNA accumulation in the presence of WT (left) and mutant (right) U2.
(C–E) ChIP analysis to detect RNAPII on the BSRibo1 gene using anti-Rpb3p antibodies. Details are as in Figures 1C–1E.
Error bars indicate standard error for qPCR performed in triplicate. See also Figure S3 for more detail and for ChIP analysis of pSer5 and pSer2.
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with pSer5 and pSer2 are evident over the 30 splice sites of all
four intron-containing genes (Figures 7A–7D). It is particularly
clear for APE2 and DBP2, which have longer first exons, that
the peak of pSer5 at the 30SS is distinct from the peak at the
promoter. In contrast, different patterns were observed for two
intronless genes, ADH1 and FMP27, with pSer5 declining andMolecpSer2 increasing from the 50 ends to the 30 ends of the genes
(Figures 7E and 7F).
DISCUSSION
The splicing-dependent transient accumulation of RNAPII was
first detected in these experiments because we performedular Cell 40, 582–593, November 24, 2010 ª2010 Elsevier Inc. 587
Figure 5. RNAPII Pauses Repeatedly at the 30 End of the Ribo1 Intron
Transcription, splicing, and RNAPII recruitment were analyzed after Ribo1
induction as described in Figure 1 but for a longer period of time. Error bars
indicate standard error for qPCR performed in triplicate. For more detail, see
also Figure S4.
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induction of an intron-containing gene. The detection of
repeated pausing events lasting probably no more than 30 s
each (Figures 5 and 6) indicates that RNAPII initiation and elon-
gation on the doxycyclin-regulated Ribo1 and APE2 genes are588 Molecular Cell 40, 582–593, November 24, 2010 ª2010 Elsevierhighly synchronous in different cells in the population, at least
for the duration of these experiments. In principle, the accumu-
lated RNAPII signal could represent sites of RNAPII arrest and
premature transcription termination. However, the amount of
Ribo1 mRNA increased very rapidly and more or less continu-
ously, usually reaching a level as high or higher than for ILRibo1.
Thus, there was no evidence of a defect in transcription and we
propose that RNAPII pauses at a splicing-dependent transcrip-
tional checkpoint.
The timing of the first observed pause after induction of the
Ribo1 gene correlates with the first detectable cotranscriptional
splicing event, as judged by the cotranscriptional recruitment of
U2 andU5 snRNPs (Figure 3) and accumulation of splicedmRNA
(Figure 1B shows RNA accumulation in the same culture).
Furthermore, in a longer experiment (Figure 5), three large peaks
of RNAPII also occurred at or immediately after peaks in pre-
mRNA accumulation and rapid rises in mRNA production, which
we propose may represent bursts of splicing activity. ChIP of
RNAPII at the promoter may also suggest bursts of transcrip-
tional activity (Figure 5C), although the periodicity differs from
that of splicing and RNAPII pausing. Synchronous bursts of tran-
scription have been observed after induction of mammalian
genes although with longer intervals than observed here (Me´tiv-
ier et al., 2008; Heim et al., 2009).
The ChIP assays with Ribo1 indicate transient accumulation of
RNAPII associated with amplicons 3 and 4 that span 180 bp
around the 30SS of Ribo1 (40 bp at the 30 end of the intron and
140 bp at the 50 end of exon2). Although amplicons 3 and 4
have overlapping sequences, they do provide some discrimina-
tion, as seen by the detection of U2 snRNP recruitment only
with amplicon 3, andofU5 snRNP recruitment onlywith amplicon
4 (Figures 3C and 3D). Therefore, RNAPII may accumulate over
a large area around the 30SS and downstream. Our data suggest
that the RNAPII pausing at the 30 end of introns is unlikely to be
sequence specific (discussed below); therefore, it may occur
wherever RNAPII happens to be on the gene at the time when
a checkpoint is triggered by the spliceosome, and this may vary
slightly betweencells in apopulation. In order to explore this issue
further, a method with higher resolution than ChIP-PCR will be
required. Although theavailable genome-widedata lack the reso-
lution and sensitivity to show a transient accumulation of RNAPII
over 30 splice sites, RNAPIIwas found to accumulate over internal
exons in humans as well as plants, Drosophila and nematodes
(Brodsky et al., 2005; Schwartz et al., 2009; Chodavarapu et al.,
2010), and especially over alternatively spliced exons in humans
(Brodsky et al., 2005). As exons in higher eukaryotes tend to be
short, these observations could be explained by the accumula-
tion of RNAPII near the 30 splice sites.
The APE2 and Ribo1 genes showed similar patterns of RNAPII
phosphorylation after induction, with pSer5 RNAPII at the
promoter, oscillating levels of pSer5 RNAPII in the region of the
30SS, and with pSer2 first detected at this point and persistently
high toward the 30 end of the genes, but not displaying the
obvious periodicity seen for pSer5 at the 30SS. Examination of
the proportion of total RNAPII that is phosphorylated indicates
that RNAPII at the 30SS is hyperphosphorylated compared to
RNAPII at the promoter (Figure S2). Also, particularly for induc-
ible APE2, little or no pSer5 RNAPII was detected between theInc.
Figure 6. RNAPII Pauses Repeatedly at the 30 End of the APE2 Intron
ChIP was performed to measure RNAPII recruitment to the APE2 gene after doxycyclin induction as described in Figure 1, amplifying the six regions indicated in
(A). Results are shown for ChIP of RNAPII at the promoter (amplicon 1), 30SS (amplicon 4), or at all positions tested (B–D, respectively), using antibodies to total
RNAPII (anti-Rpb3p; left), pSer5 (4H8 antibodies; middle) or pSer2 (H5 antibodies; right). Error bars indicate the standard error for qPCR performed in triplicate.
For more detail, see also Figure S5.
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30SS is newly phosphorylated. The evidence of hyperphosphor-
ylation of RNAPII over the 30 splice sites of constitutively
expressed genes in a population of cells growing underMolecsteady-state conditions suggests that this may be a common
event in yeast.
Thefindingof strongly phosphorylatedRNAPII pausednear the
30 ends of the Ribo1 and APE2 introns is compatible withular Cell 40, 582–593, November 24, 2010 ª2010 Elsevier Inc. 589
Figure 7. Phosphorylated RNAPII Accumulates around the 30 Splice Sites of Endogenous Yeast Intron-Containing Genes
ChIP analysis was performed to detect RNAPII with pSer5 (4H8 antibodies, black) or pSer2 (H5 antibodies, gray) along the lengths of the intron-containing genes
ASC1, ACT1, DBP2, and APE2 and the intronless genes ADH1 and FMP27, all of which are constitutively expressed in yeast cells grown under steady-state
conditions. Results are presented as the percentage of input relative to total RNAPII. Error bars indicate standard error for qPCR performed for three different
cultures, each assayed in triplicate. Numbers indicate the positions of primers used for qPCR relative to the start codon of each open reading frame. Vertical
arrows indicate the positions of the 30SS, and in the line drawings, the thick lines indicate the positions of exons with respect to the PCR amplicons. For total
RNAPII (anti-Rpb3p) ChIP data, see also Figure S6.
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found in the 50 region of genes at transcription initiation and is
also associated with promoter proximal pausing, whereas
pSer2 is associated with elongating RNAPII (Buratowski, 2009).
We propose the existence of a transcriptional checkpoint, in
whichRNAPII pauses transiently near 30 splice siteswith an asso-
ciated phosphorylation of Ser5 in the CTD. Conceivably, phos-
phorylation of Ser2 of the CTD at the same position on the gene
may be associated with release from the proposed checkpoint.590 Molecular Cell 40, 582–593, November 24, 2010 ª2010 ElsevierpSer5 is not commonly found within the body of a gene, but it
is not unknown. For example, hyperphosphorylation of RNAPII
and inhibition of transcriptional elongation was observed after
ultraviolet-induced DNA damage that causes changes to cotran-
scriptional alternative splicing in mammalian cells (Mun˜oz et al.,
2009). Also, human Brm, the ATPase component of the chro-
matin remodeling complex SWI/SNF, affects the alternative
splicing of a number of transcripts, apparently by inducing the
accumulation of RNAPII with pSer5 on the variant exons ofInc.
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Splicing-Dependent RNA Polymerase Pausing in Yeastaffected genes (Batsche´ et al., 2006). This was proposed to
reflect a decreased elongation rate or pausing of RNAPII by
Brm that would, in turn, favor inclusion of the variable exons in
the mRNA. Thus, Brm was proposed to mediate crosstalk
between transcription and RNA processing by directly or indi-
rectly affecting the phosphorylation status of RNAPII (reviewed
by Kornblihtt, 2006).
Although mutation of the 50SS, BS, or 30SS of the Ribo1
reporter intron abolished pausing at the 30SS, pausing was
restored by suppression in trans of the splicing defect of the
BSRibo1 mutant transcript. Thus, it seems to be the splicing
event rather than the sequence of the intron that actually triggers
RNAPII pausing. The failure of 30SSRibo1 mutant to cause this
pause suggests that it may be triggered as a consequence of
the assembly of spliceosomes that are competent to perform
the second step of splicing (or more specifically by the recruit-
ment of a second step splicing factor), and it could be the
completion of the second step reaction that releases the pause.
Interestingly, with the 30SSRibo1 mutant, there was
a pronounced accumulation of pSer5 modified RNAPII on the
exon1/50SS region of the gene (Figure 2D, left panel, amplicon 2),
and a reduced amount of total RNAPII at the promoter (Fig-
ures 1C and 1E) compared with the splicing-competent Ribo1
gene. We propose that this may indicate the existence of an
earlier checkpoint that is triggered by the splicing defect of
30SSRibo1 transcripts, possibly resulting in reduced promoter
activity.
As spliceosome assembly takes place cotranscriptionally it
seems likely that splicing factors may mediate the RNAPII pause
either by direct interaction or via chromatin-associated factors.
Many splicing factors have been shown to interact with RNAPII
complexes, including yeast Prp40p (Morris and Greenleaf
2000), and human SR proteins and U1 snRNP components
(Das et al., 2007). There have been several reports of splicing
factors affecting transcription (for reviews, see Fededa and
Kornblihtt, 2008; Pandit et al., 2008). For example human U
snRNPs were shown to strongly stimulate RNAPII elongation
through interaction with the transcription elongation factor
TAT-SF1 that, in turn, interacts with elongation factor P-TEFb
(Fong and Zhou, 2001). Human SC35 also appears to stimulate
transcription through interaction with P-TEFb (Lin et al., 2008).
The P-TEFb complex contains the CDK9 kinase that binds to
pSer5 and phosphorylates Ser2 of the CTD. Depletion of SC35
caused a transcription elongation defect and RNAPII was
observed to accumulate on the body of certain genes, with
a concomitant reduction in P-TEFb recruitment and of pSer2.
In view of our observations with yeast, we suggest that SC35
depletion may have triggered a transcriptional checkpoint
response either directly through lack of interaction of SC35
with P-TEFb, or indirectly by causing a splicing defect at the
affected genes.
The human SKIP protein is another factor that was reported to
activate transcription through interaction with P-TEFb, in this
case enhancing Tat-regulated elongation at the HIV-1 promoter
(Bre`s et al., 2005). SKIP (Prp45p in yeast) is both a coregulator of
transcription (Bre`s et al., 2005; Bre`s et al., 2009) and an essential
component of spliceosomes (Albers et al., 2003; Makarova et al.,
2004). SKIP is therefore a candidate coupling or checkpointMolecfactor that could mediate functional links between the two
processes. Other candidates are the DExD/H-box RNA heli-
cases, eight of which are involved in splicing in budding yeast.
There is evidence that several of these proteins function as
splicing fidelity factors, determining whether splicing should
proceed to the next stage or the RNA should be discarded
(Burgess and Guthrie, 1993; Mayas et al., 2006; Xu and Query,
2007; Query and Konarska, 2006).
A splicing-dependent transcriptional checkpoint might exist at
the 30 ends of introns simply to promote cotranscriptional
splicing or, especially in metazoans, to enhance use of that
particular 30SS. Alternatively, multiple transcriptional check-
points might exist that function as part of a surveillance mecha-
nism in response to signals from fidelity factors at different
stages during the splicing cycle, from spliceosome assembly
to release of the spliced products. This would suggest a highly
complex series of interactions, involving many factors. The
system described here, using high-resolution kinetic assays in
an organism that is amenable to genetics, provides a means to
investigate the mechanism behind the proposed checkpoint(s)
and identify the factors involved.
EXPERIMENTAL PROCEDURES
The Ribo reporter genes under control of a tet-O7/CYC1-UAS promoter (Bellı´
et al., 1998) were integrated at the his3 locus in the tetON strain YIK91 or in the
tetOFF strain YIK120 (Alexander et al., 2010). The doxycyclin-inducible APE2
gene was constructed in a similar way in the tetON strain. See the Supple-
mental Information for details of strains (Table S1) and sequences of the
Ribo reporter genes. Cultures were grown in synthetic dropout (SD) medium
(Foremedium) at 30C and doxycyclin was added to 4 mg/ml to induce or
repress reporter gene expression. For RNA extraction, 10ml aliquots of culture
were pipetted into 5 ml of methanol at 70C, pelleted, and stored at 70C.
RNA extraction (Tollervey and Mattaj 1987) and RT-qPCR were performed as
described in the Supplementary Experimental Procedures, using primers as in
Table S2. For ChIP analysis, 40 ml aliquots of culture were crosslinked for
10 min with 1% (v/v) formaldehyde and treated as described at http://www.
ribosys.org/, using antibodies against Rpb3p (Neoclone), 4H8 antibodies
(Millipore), or H5 antibodies (Covance). The DNA fragments (average size
350 bp) were amplified by qPCR using primers listed in Tables S2 and S3.
ChIP experiments to detect phosphorylated RNAPII epitopes were performed
at sub-saturating antibody titers (5-fold less than recommended by Kim et al.
[2009]). ChIP data for the kinetic experiments are presented as percentage of
input relative to uninduced level at T0. ChIP data for pSer RNAPII in Figure 7
and Figure S2 (right panels) are presented as the percentage of input relative
to total RNAPII. Experiments presented in Figures 5 and 6 were performed in
biological duplicate, and all other experiments were performed at least in trip-
licate, with all qPCR assays also performed in triplicate. In each case, a repre-
sentative experiment is shown.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three tables and can be found with this article online at
doi:10.1016/j.molcel.2010.11.005.
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